McCall, Matthew B B <br/><br/>
No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria.  [electronic resource] 

 -  Transactions of the Royal Society of Tropical Medicine and Hygiene  Dec 2006 
 - 1098-104 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0035-9203 
<br/><br/><label>Standard No.: </label>10.1016/j.trstmh.2006.02.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antimalarials--adverse effects<br/>Artemether, Lumefantrine Drug Combination<br/>Artemisinins--adverse effects<br/>Audiometry, Pure-Tone<br/>Drug Combinations<br/>Ethanolamines--adverse effects<br/>Evoked Potentials, Auditory, Brain Stem<br/>Female<br/>Fluorenes--adverse effects<br/>Hearing Loss--chemically induced<br/>Humans<br/>Malaria, Falciparum--drug therapy<br/>Male